Kouzuki, Minoru
Miyamoto, Madoka
Tanaka, Nobuto
Urakami, Katsuya
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP19K19460)
Article History
Received: 27 September 2022
Accepted: 1 December 2022
First Online: 7 December 2022
Declarations
:
: The ethics committee of Tottori University faculty of Medicine (Yonago, Japan) approved the design of this study (number: 20A228), conducted by following the tenets of the Declaration of Helsinki. We explained the research protocol to the patients and guardians as necessary, who provided written informed consent for participation.
: Not applicable.
: MK, MM, and NT have no conflicts of interest to declare. KU owns a patent on the computerized test battery for Alzheimer’s disease screening (produced by Nihon Kohden Corporation, named “<i>monowasure soudan proguramu</i> (MSP)” (forgetfulness consultation program)), and receives royalties from Nihon Kohden Corporation.